Description
Balicatib is an inhibitor of cathepsin K that displays anti-resorptive activity. Balicatib inhibits osteoclast activity, decreasing bone turnover and increasing bone mineral density and bone formation rates.
Product Unit Size | Cost | Quantity | Stock |
---|
Balicatib is an inhibitor of cathepsin K that displays anti-resorptive activity. Balicatib inhibits osteoclast activity, decreasing bone turnover and increasing bone mineral density and bone formation rates.
Cas No. | 354813-19-7 |
---|---|
Purity | ≥98% |
Formula | C23H33N5O2 |
Formula Wt. | 411.55 |
IUPAC Name | N-{1-[(Cyanomethyl)carbamoyl]cyclohexyl}-4-(4-propyl-1-piperazinyl)benzamide |
Synonym | AAE-581 |
Solubility | DMSO: ≥ 46 mg/mL |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Jerome C, Missbach M, Gamse R. Balicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys. Osteoporos Int. 2012 Jan;23(1):339-49. PMID: 21380636.
Chappard D, Libouban H, Mindeholm L, et al. The cathepsin K inhibitor AAE581 induces morphological changes in osteoclasts of treated patients. Microsc Res Tech. 2010 Jul;73(7):726-32. PMID: 20025055.
Derivative of methyl caffeate, hydroxycinnamic ...
Alkaloid compound found in Corydalis.
Polyether cationic ionophore.
Anthracycline, DNA intercalator; topoisomerase ...
Synthetic derivative of glycyrrhizin; connexin ...
Mycotoxin produced by species of Aspergillus; D...
BHA derivative; potential Ca2+ ATPase inhibitor...
Coccidiostat; dihydrofolate reductase inhibitor...
TRPC5 activator, NS4B and histamine H1 inhibito...
Raf inhibitor.
Oxidized non-cylic hexose sugar.
Isoflavone daidzein derivative found in Puerari...
RORα/γ inverse agonist.
Synthetic steroid; glucocorticoid agonist.
NSAID; COX-1/2 inhibitor.
Aspartyl protease inhibitor.
MEK1/2 and Raf inhibitor.
Tetracyclic sesterpenoid phytotoxin.
TRPV4 agonist